InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Connaughton Bernadette, Director. Officer active across 2 companies, notably Halozyme Therapeutics, INC.. Aggregated, 18 filings have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €717k. Activity tracked since 5 May 2021. The latest transaction was filed on 10 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Connaughton Bernadette
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
1,626 shares@ US$102.80Common StockSEC:0001662521-26-000002:0
1,625 shares@ US$66.210.0011% mcap18.2% of flowCommon StockSEC:0001159036-26-000072:0
1,625 shares@ US$63.480.0011% mcap21.1% of flowCommon StockSEC:0001159036-26-000055:0
2,000 shares@ US$70.250.0015% mcap28.9% of flowCommon StockSEC:0001159036-26-000006:0
829 shares@ US$71.608.9% of flowCommon StockSEC:0001159036-25-000065:0
2,000 shares@ US$68.4822.8% of flowCommon StockSEC:0001159036-25-000052:0
1,500 shares@ US$75.08623.8% of flowCommon StockSEC:0001662521-25-000005:0
100 shares@ US$71.712.0% of flowCommon StockSEC:0001415889-25-023470:0
4,165 shares0Common StockSEC:0001415889-25-011767:0
6,501 shares0Common StockSEC:0001415889-24-011679:0
9,915 shares@ US$43.00100.0% of flowClass A Common StockSEC:0001209191-23-050772:0
4,863 shares0Class A Common StockSEC:0001209191-23-032940:0
8,065 shares0Common StockSEC:0001415889-23-007688:0
5,998 shares0Common StockSEC:0001415889-22-011511:0
2,839 shares0Class A Common StockSEC:0001209191-22-032624:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002907:0
2,364 shares0Class A Common StockSEC:0001209191-21-032806:0
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004970:0
18 of 18 declarations
About Connaughton Bernadette
Connaughton Bernadette is a Director at Halozyme Therapeutics, INC. and Syneos Health, Inc. She has 17 filings in total. In the sampled recent filings from 2021-05-06 to 2026-06-02, the total sell amount is EUR 976217 and the most frequent transaction nature is Attribution.
